Savvy Updates, 2/14/22: Spare a Rose Save a Life (IDF), Eversense 180-day Implanted CGM Approved by FDA, Faster/Better Delivery Insulin, Valentines for a T1D
An AMAZING way to celebrate Valentine’s Day … and support a child with T1D! For a most impactful gift, you can make a beautiful and immeasurably powerful statement by support the Spare a Rose campaign. Spare a Rose is about making a small donation to...
Savvy Setting, 2/9/22: A New Perspective on ISF (Insulin Sensitivity Factor) with Chris Wilson
THIS IS AN IMPORTANT TOPIC! And this may dramatically change how you look at your insulin sensitivity factor … and how you manage the variability in your blood sugars. We’ve been doing it wrong. Doctors and researchers have known that ISF...
Savvy Updates, 2/7/22: Novo Nordisk, Lilly, Novartis Accused of Price Collaboration, Double Diabetes, Beta Cell Pathway Discovered, Lighting & Lower BG, FDA & D Device Interoperability, Dr. Pettus Got Covid
Novo Nordisk challenges House report it collaborated with competitors on insulin prices was written by Jonathan Block for SeekingAlpha.com, 2 February 2022. Novo Nordisk CEO Lars Joergensen struck back at a House Oversight Committee report issued in...
Savvy Updates 1/31/22: Omnipod 5 FDA Release, Nanocarriers for Islet Cells, Highest HbA1c in History
Omnipod 5: Automated Insulin Delivery System, First Tubeless System with Smartphone Control APPROVED by the US FDA, as announced by Insulet.com, 28 January 2022. On January 28, 2022, Insulet announced the FDA clearance of the Omnipod 5 Automated Insulin...
Savvy Update, 1/24/22: Updates from Kevin Sayer/Dexcom and John Sheridan/Tandem, Vitamin D Preserves Beta Function, DIY APS Offers Best Results, T1D Many Types?, Lyumjev Update, Mark Cuban’s CostPlus Drug Service
Dexcom CEO on G7’s global launch, COVID-19 slowing new patient adds, international growth was reported by Ricky Zipp for MedTechDive.com, 18 January 2022. After proving fairly resilient throughout the last two years, even as other medtechs were...
More Diabetes Blogs